Business automation software provider Upland Software (NASDAQ: UPLD) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 10% year on year to $63.66 million. On the other hand, next quarter’s revenue guidance of $53.3 million was less impressive, coming in 11.7% below analysts’ estimates. Its non-GAAP profit of $0.23 per share was 32.7% above analysts’ consensus estimates.
Electronic system and device provider Bel Fuse (NASDAQ:BELFA) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 18.9% year on year to $152.2 million. Its GAAP profit of $1.36 per share was 64.8% above analysts’ consensus estimates.
Health care services provider Encompass Health (NYSE:EHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 10.6% year on year to $1.46 billion. The company’s full-year revenue guidance of $5.89 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $1.37 per share was 15% above analysts’ consensus estimates.
Uncover the potential of ADVANCED MICRO DEVICES, a growth stock reasonably priced. NASDAQ:AMD is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.
Cable news and media network Fox (NASDAQ:FOXA) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 26.8% year on year to $4.37 billion. Its non-GAAP profit of $1.10 per share was 22.6% above analysts’ consensus estimates.
Education company Lincoln Educational (NASDAQ:LINC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 13.7% year on year to $117.5 million. The company’s full-year revenue guidance of $490 million at the midpoint came in 1.2% above analysts’ estimates. Its GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.
CNBC Commentator, Jim Cramer has raised concerns over the constitutionality of recent drug price controls, urging pharmaceutical companies to seek an injunction.
